BLAKE POWERS: Open Payments
NPI 1023651007 · ATHENS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 42 payments from 15 companies in 2025. Trend: 2023 $641 · 2024 $569 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $168 |
| PFIZER INC. | 9 | $149 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Amgen Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Exact Sciences Corporation | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: PREVNAR 20, Ozempic, GVOKE HYPOPEN, Wegovy, Rybelsus, REPATHA, ELIQUIS, SHINGRIX.
Industry payments across TN — which companies pay providers there.
